您当前的位置：
首页 >
文章列表页 >
Efficacy and safety analysis of ceftazidime/avibactam combined with amikacin in the treatment of severe pneumonia caused by CRE infection
更新时间：2025-11-10

    • Efficacy and safety analysis of ceftazidime/avibactam combined with amikacin in the treatment of severe pneumonia caused by CRE infection

    • “A study conducted by Xuzhou Medical University Affiliated Hospital shows that the combination of cefotaxime/avibactam and amikacin has significant efficacy and good safety in the treatment of severe pneumonia caused by drug-resistant Escherichia coli.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 21, Pages: 2705-2710(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.21.15    

      CLC： R563.1;R978.1

    • Received：07 July 2025，

      Revised：2025-07-30，

      Accepted：13 October 2025，

      Published：15 November 2025

    移动端阅览

  • ZHANG Tianqi,CHEN Bi,ZHANG Cantang.Efficacy and safety analysis of ceftazidime/avibactam combined with amikacin in the treatment of severe pneumonia caused by CRE infection[J].ZHONGGUO YAOFANG,2025,36(21):2705-2710. DOI： 10.6039/j.issn.1001-0408.2025.21.15.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

阿德福韦酯联合拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察
我院门诊2012年2月－2013年2月含血管紧张素Ⅱ受体拮抗药处方分析

Related Author

项波
董迪 张丽芳 郑策 甄健存

Related Institution

No data
0